Depression and insomnia often occur together. Someone with depression may lie awake with a racing mind, and someone who isn't sleeping properly often finds it much harder to lift their mood. Despite this overlap, treatment tends to focus on one problem at a time, with the hope that the other improves along the way.
A randomised controlled trial by Carney and colleagues examined a more direct approach. The study compared cognitive behavioural therapy for insomnia (CBT-I), combined with antidepressant medication, against treatments that targeted only depression or only insomnia on their own. CBT-I is a structured, evidence-based therapy that works on the habits and thought patterns that keep sleep problems going, rather than relying on medication for sleep alone. A randomised controlled trial is considered a reliable way to test whether a treatment approach genuinely helps, because participants are assigned to different treatments by chance, which allows fairer comparison between groups.
The question the researchers set out to answer was a practical one: for people dealing with both depression and insomnia, is it more effective to treat both conditions together, rather than choosing one as the priority?
If poor sleep and low mood have been feeding into each other for you, it can be difficult to know where to start. A psychologist or GP can help you work out a plan that takes both into account, and it's worth reaching out if this sounds familiar.
What the study did
Carney et al. ran a blinded, randomised controlled trial (a study design where participants are assigned by chance to different treatments, and where possible the assessors don't know who received what, to reduce bias) across two urban academic clinics. 107 adults (68% female, average age 42) who had both major depressive disorder and insomnia were split into three groups: an antidepressant (escitalopram, a commonly used SSRI) plus four sessions of CBT-I (cognitive behavioural therapy for insomnia — a structured, skills-based therapy that targets the thoughts and habits keeping insomnia going); CBT-I plus a placebo pill (an inactive pill used so the medication effect can be isolated); or the antidepressant plus four sessions of sleep hygiene education (SH), a control condition offering only general sleep advice rather than active insomnia therapy.
Sleep was measured two ways: subjectively, through two weeks of daily sleep diaries before and after treatment, and objectively, through overnight polysomnography (PSG) — a lab-based sleep study that records brain waves, eye movement and other signals to measure sleep directly rather than relying on memory. Depression severity was tracked using the HAMD-17, a widely used clinician-rated depression scale.
What it found
On self-reported sleep, all three groups improved from before to after treatment on sleep efficiency (the proportion of time in bed actually spent asleep) and total wake time, with large effect sizes (a way of describing how big and meaningful a change is, beyond just whether it's statistically significant). There were no significant differences between groups on these self-reports.
But the objective PSG data told a more nuanced story: both CBT-I groups improved on total wake time, while the antidepressant-plus-sleep-hygiene group actually got worse on this measure. There was a medium-sized difference between the AD+SH and CBT-I+placebo groups on diary total wake time and on both PSG measures, favouring CBT-I. In other words, people in the AD+SH group felt like their sleep had improved, even though objectively it hadn't — and had in some ways worsened.
On depression, all three groups improved significantly on the HAMD-17, with no differences between groups. Strikingly, this included the CBT-I plus placebo group — people who received no active depression-focused treatment at all, yet still improved on depression.
Why it matters
This suggests two important things. First, relying only on how people say they're sleeping can hide real problems — sleep can worsen objectively even while someone reports feeling better, particularly when insomnia itself isn't being directly treated. Second, CBT-I appears to carry benefits for mood even without an antidepressant on board, echoing findings from other research and raising the possibility that treating insomnia directly has its own antidepressant-like effects worth investigating further.
Limits worth knowing
This was one trial, in a specific adult sample, using specific treatments (escitalopram, four-session CBT-I) and comparisons — it doesn't tell us this pattern holds for every antidepressant, every insomnia therapy, or every age group. Some key comparisons (like PSG sleep efficiency) weren't statistically significant, so caution is warranted.
If sleep and mood have been tangling with each other for you, that's a genuinely common and treatable pattern — reaching out to a psychologist or GP is a solid first step.